{"id":"W4385707156","doi":"10.1097/01.hs9.0000971348.10013.c4","title":"P1113: COMPARATIVE EFFICACY OF ZANUBRUTINIB (ZANU) VERSUS RITUXIMAB (RTX) IN RELAPSED MARGINAL ZONE LYMPHOMA (MZL): MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Medicine; Propensity score matching; Oncology; Internal medicine; Progression-free survival; Rituximab; Population; Overall survival; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007904184,0.00048948,0.001734488,0.0004532877,0.0001288341,0.00003424193,0.0004348707,0.0003629843,0.0009926729],"category_scores_gemma":[0.0003600161,0.00046852,0.0002718859,0.002638298,0.0003853925,0.0001079023,0.0003159372,0.0006024887,0.001372479],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005768656,"about_ca_system_score_gemma":0.003955799,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001974814,"about_ca_topic_score_gemma":0.0008666079,"domain_scores_codex":[0.99532,0.0003076353,0.001114152,0.0008064516,0.001339574,0.001112231],"domain_scores_gemma":[0.9966101,0.001540036,0.0003344998,0.0009345888,0.0002162605,0.0003644943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2728759,0.04142116,0.06185462,0.01467007,0.007836364,0.02341343,0.1344102,0.01659283,0.03285926,0.01102446,0.2314918,0.1515499],"study_design_scores_gemma":[0.6450804,0.003988561,0.1788565,0.003816487,0.0005349849,0.00054418,0.02471729,0.08567663,0.0405237,0.0002249112,0.014208,0.001828284],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9800344,0.001040295,0.00005414971,0.0002516384,0.0004310675,0.00125671,0.00003175942,0.0003300098,0.01657],"genre_scores_gemma":[0.9952255,0.00008381084,0.0009596959,0.00004694824,0.0001704512,0.00008230671,0.0002265884,0.00008804035,0.003116603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3722045,"threshold_uncertainty_score":0.9999205,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09647680593430397,"score_gpt":0.3711941144409404,"score_spread":0.2747173085066364,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}